Nonsteroidal anti-inflammatory drug use and the risk of melanoma: A meta-analysis

European Journal of Cancer Prevention

Volumn 23, Issue 1, 2014, Pages 62-68

  Hu, Huabin ^a   Xie, Yangchun ^b   Yang, Guorong ^b   Jian, Chengzhu ^c   Deng, Yanhong ^a  

^a THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Aspirin; Chemoprevention; Melanoma; Meta analysis; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CANCER RISK; DRUG USE; HUMAN; MELANOMA; META ANALYSIS; PRIORITY JOURNAL; SKIN COLOR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; HUMANS; MELANOMA; PROGNOSIS; RISK FACTORS;

EID: 84889251493     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328360f479     Document Type: Article

References (45)

1. Anstey AV (2002). Systemic photoprotection with alpha-tocopherol (vitamin E) and beta carotene. Clin Exp Dermatol 27:170-176.
2. Asgari MM, Maruti SS, White E (2008). A large cohort study of nonsteroidal antiinflammatory drug use and melanoma incidence. J Natl Cancer Inst 100:967-971. (Pubitemid 351957509)
3. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
4. Cochran WG (1954). The combination of estimates from different experiments. Biometrics 10:101-129.
5. Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. (2005). Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294:47-55. (Pubitemid 41002838)
6. Corley DA, Kerlikowske K, Verma R, Buffler P (2003). Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and metaanalysis. Gastroenterology 124:47-56. (Pubitemid 36055338)
7. Curiel-Lewandrowski C, Nijsten T, Gomez ML, Hollestein LM, Atkins MB, Stern RS (2011). Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case- control study. J Invest Dermatol 131:1460-1468.
8. Denkert C, Kobel M, Berger S, Siegert A, Leclere A, Trefzer U, Hauptmann S (2001). Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61:303-308. (Pubitemid 32095731)
9. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
10. Dubé C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, Code C, et al. U.S. Preventive Services Task Force (2007). The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146:365-375. (Pubitemid 351650597)
11. Egger M, Smith GD, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple graphical test. BMJ 315:629-634. (Pubitemid 27387172)
12. Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, Conti CJ (1999). Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 25:231-240. (Pubitemid 29372908)
13. Friis S, Sørensen HT, McLaughlin JK, Johnsen SP, Blot WJ, Olsen JH (2003). A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 88:684-688. (Pubitemid 36411444)
14. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, Melchi CF (2005). Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41:45-60. (Pubitemid 40029658)
15. Gilchrest BA, Eller MS, Geller AC, Yaar M (1999). The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340:1341-1348. (Pubitemid 29196597)
16. Glynn SA, O'Sullivan D, Eustace AJ, Clynes M, O'Donovan N (2008). The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells. BMC Cancer 8:9.
17. Greenland S (1987). Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9:1-30.
18. Gupta RA, Dubois RN (2001). Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1:11-21. (Pubitemid 33741877)
19. Harris RE, Beebe-Donk J, Namboodiri KK (2001). Inverse association of nonsteroidal anti-inflammatory drugs and malignant melanoma among women. Oncol Rep 8:655-657.
20. Higgins JPT, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. (Pubitemid 34746062)
21. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ 327:557-560. (Pubitemid 37088507)
22. Hwang ES, Bowen PE (2001). Can the consumption of tomatoes or lycopene reduce cancer risk? Integr Cancer Ther 1:121-132.
23. Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle EE (2007). A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99:608-615. (Pubitemid 47073542)
24. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin 61:69-90.
25. Jeter JM, Bonner JD, Johnson TM, Gruber SB (2011). Nonsteroidal anti-inflammatory drugs and risk of melanoma. J Skin Cancer 2011:598571.
26. Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB, Sørensen HT (2012). Nonsteroidal anti-inflammatory drugs and the risk of skin cancer. Cancer 118:4768-4776.
27. Joosse A, Koomen ER, Casparie MK, Herings RM, Guchelaar HJ, Nijsten T (2009). Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study. J Invest Dermatol 129:2620-2627.
28. Kim ES, Hong WK, Khuri FR (2002). Chemoprevention of aerodigestive tract cancers. Annu Rev Med 53:223-243. (Pubitemid 34177880)
29. Larsson SC, Giovannucci E, Bergkvist L, Wolk A (2006). Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:2561-2564. (Pubitemid 46048323)
30. Mahmud SM, Franco EL, Aprikian AG (2010). Use of nonsteroidal antiinflammatory drugs and prostate cancer risk: a meta-analysis. Int J Cancer 127:1680-1691.
31. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
32. Ming ME (2011). The search for a chemoprevention agent effective against melanoma: considerations and challenges. J Invest Dermatol 131:1401-1403.
33. Minichsdorfer C, Hohenegger M (2009). Autocrine amplification loop in statininduced apoptosis of human melanoma cells. Br J Pharmacol 157: 1278-1290.
34. Oh SW, Myung SK, Park JY, Lee CM, Kwon HT. Korean Meta-analysis (KORMA) Study Group (2011). Aspirin use and risk for lung cancer: a meta-analysis. Ann Oncol 22:2456-2465.
35. Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R (1999). Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 20:1939-1944. (Pubitemid 29476120)
36. Sabichi AL, Lippman SM (2004). COX-2 inhibitors and other nonsteroidal antiinflammatory drugs in genitourinary cancer. Semin Oncol 31 (Suppl 7): 36-44. (Pubitemid 38879413)
37. Saito A, Saito N, Mol W, Furukawa H, Tsutsumida A, Oyama A, et al. (2008). Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells. Melanoma Res 18:85-94. (Pubitemid 351398262)
38. Sørensen HT, Friis S, Nørgård B, Mellemkjaer L, Blot WJ, McLaughlin JK, et al. (2003). Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 88:1687-1692. (Pubitemid 36760410)
39. Takkouche B, Regueira-Méndez C, Etminan M (2008). Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 100:1439-1447.
40. Thun MJ (2000). Beyond willow bark: aspirin in the prevention of chronic disease. Epidemiology 11:371-374. (Pubitemid 30428926)
41. Thun MJ, Henley SJ, Patrono C (2002). Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94:252-266. (Pubitemid 34196319)
42. Tian W, Zhao Y, Liu S, Li X (2010). Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev 19:288-298.
43. Whiteman DC, Whiteman CA, Green AC (2001). Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12:69-82. (Pubitemid 32125902)
44. Yang P, Zhou Y, Chen B, Wan HW, Jia GQ, Bai HL, Wu XT (2010). Aspirin use and the risk of gastric cancer: a meta-analysis. Dig Dis Sci 55: 1533-1539.
45. Zhao YS, Zhu S, Li XW, Wang F, Hu FL, Li DD, et al. (2009). Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis. Breast Cancer Res Treat 117:141-150.